Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2/3 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 2Thoracic 1Sarcoma 1Head & Neck 1Gastrointestinal 1Dermatologic 1

Conditions

Urogenital Neoplasms 1Sarcoma 1Melanoma 1Lung Neoplasms 1Head and Neck Neoplasms 1Colorectal Neoplasms 1Breast Neoplasms 1

Interventions

Nivolumab 7pembrolizumab 5Ipilimumab 4Interferon alpha-2 3relatlimab 2Etoposide 2Drug Therapy 2Dacarbazine 2Cyclophosphamide 2sargramostim 1salicylhydroxamic acid 1pertuzumab 1peginterferon alfa-2b 1peginterferon alfa-2a 1molgramostim 1green tea extract polyphenone E 1fludarabine phosphate 1entrectinib 1cyclopropapyrroloindole 1cobimetinib 1atezolizumab 1Whole-Body Irradiation 1Vincristine 1Vemurafenib 1VAP-cyclo protocol 1Triamcinolone Acetonide 1Trastuzumab 1Thiotepa 1Temozolomide 1Surgical Procedures, Operative 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × Atorvastatin × Dermatologic × Clear all
NCT01259284 2012-08-07

Fish Oil Versus Statins Versus Placebos in Reducing Atrial Fibrillation in Patients Undergoing Thoracic Surgery for Lung Cancer

M.D. Anderson Cancer Center

Phase 2/3 Terminated
2 enrolled 4 charts
BreastDermatologicGastrointestinalHead & NeckSarcomaThoracic

Breast Neoplasms, Head and Neck Neoplasms, Lung Neoplasms, Melanoma, Sarcoma, Urogenital Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡